Evidence suggests that women with myeloproliferative neoplasms have a higher risk of maternal and fetal complications. In this data analysis, researchers evaluated outcomes for pregnant women with essential thrombocythemia, polycythemia, or myelofibrosis and their infants.
Pregnancy screening rates before teratogenic exposures are low for female adolescent patients with acute leukemia and those with ER visits including abdominal/pelvic CT.
The BRCA1 mutation may speed the aging of a woman's ovaries,according to a recent report.
Among women aged up to 49 years with a pregnancy-associated melanoma, recurrence rates were higher than seen in other groups.
A recent study showed that women younger than 50 years who are pregnant or were recently pregnant at diagnosis of melanoma have a higher risk of death from the skin cancer.
Prenatal exposure to maternal cancer, with or without treatment, does not appear to impact early child development, a study found.
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.
The risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is increased in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.
Abnormal findings on early test don't always indicate birth defects, researchers say, but could instead indicate cancer.
Embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility for patients with breast cancer, according to a study published online.
Non-invasive prenatal testing (NIPT) can be employed as a less-invasive means to detect cancer in expecting mothers.
Breast cancer during pregnancy presents additional psychosocial challenges as patients cope with a devastating diagnosis during a time of hope and promise for the future.
Female meningioma survivors are more likely to want and to become pregnant than the general population, and some research indicates that pregnancy may be a risk factor for tumor progression or recurrence.
Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.
This fact sheet examines the relationship between oral contraception and risk of breast, ovarian, endometrial, liver, and cervical cancers.
International team assessed the impact of cancer treatment on children of women pregnant at diagnosis or during treatmentOctober 15, 2014
A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.
Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian, and uterine cancers, new research indicates, but researchers still urge long-term monitoring.
A new study has found that the levonorgestrel-releasing intrauterine system, or progesterone-releasing IUD, may be associated with a higher than expected incidence of breast cancer.
Increased odds for spontaneous abortions, stillbirths, and ectopic pregnancies were seen for smokers, compared to never-smoking women.
Fertility concerns are common among young women with newly diagnosed breast cancer, although only a minority pursue fertility preservation strategies.
Linear dose-response relationship for acute lymphoblastic leukemia and acute myeloid leukemia has been observed.
Risk the same as found in women in the general population with regard to oral contraceptive use.
Hemodynamic changes associated with pregnancy explain the growth of benign tumors in pregnant women. The study also identified some key characteristics associated with rapid growth of meningiomas in pregnant women.
Adverse events more common for infants exposed to chemo in utero; mainly due to premature birth.
Men report routine sperm banking; however, women are rarely presented with fertility preserving options.
Exposure to antineoplastic drugs and sterilizing agents are linked with a significantly increased risk of miscarriage.
Relapse rates are the same regardless of estrogen receptor status of tumor.
Interested patients should be referred to a reproductive endocrinologist as quickly as possible after a cancer diagnosis, as some fertility-preservation options require 2 to 3 weeks to complete.
Being diagnosed with cancer during pregnancy or while breastfeeding is not generally associated with increased risk of cancer-related death, researchers in Norway have found.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|